This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.35% per year. These returns cover a period from January 1, 1988 through December 2, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News for RMD
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions
5 Sectors and Stocks Set to Shine This Earnings Season
RMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues
PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
Other News for RMD
Top 50 High Quality Dividend Growth Stocks - January 2025
Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD)
ResMed Inc (RMD) Announces Upcoming Q2 Fiscal 2025 Earnings Release
Healthcare sector's 2024 gainers and losers: Intuitive Surgical, Boston Scientific tops chart
ResMed Inc (RMD) to Present at 43rd Annual J.P. Morgan Healthcare Conference